Integrated BioPharma (OTCMKTS:INBP) Shares Cross Below Fifty Day Moving Average – What’s Next?

Integrated BioPharma Inc. (OTCMKTS:INBPGet Free Report)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.18 and traded as low as $0.1602. Integrated BioPharma shares last traded at $0.1602, with a volume of 4,000 shares changing hands.

Integrated BioPharma Price Performance

The stock has a market capitalization of $4.96 million, a P/E ratio of -2.29 and a beta of 0.35. The stock’s fifty day moving average is $0.18 and its two-hundred day moving average is $0.25.

Integrated BioPharma (OTCMKTS:INBPGet Free Report) last released its quarterly earnings data on Friday, May 8th. The company reported ($0.03) earnings per share for the quarter. The company had revenue of $10.11 million for the quarter. Integrated BioPharma had a negative return on equity of 8.32% and a negative net margin of 3.43%.

Integrated BioPharma Company Profile

(Get Free Report)

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.

Recommended Stories

Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.